Home/Calyxo/Doug Hughes

DH

Doug Hughes

Chief Financial Officer

Therapeutic Areas

Urology Nephrolithiasis (Kidney Stones)

Calyxo Pipeline

Drug	Indication	Phase
CVAC System / SURE Procedure	Kidney Stone Treatment (Nephrolithiasis)	Approved

Leadership Team at Calyxo

Joe Catanese III, PhD

President and Chief Executive Officer

Founder and Chief Business Officer

Chris Buchko, PhD, JD

General Counsel

Vice President, People

Senior Vice President, Research and Development

View full Calyxo profile